Literature DB >> 26731986

miR-31 Reduces Cell Growth of Papillary Thyroid Carcinoma by RNA-Binding Protein HuR.

Danping Wu, Bo Wang, Jiangfeng Shang, Jia Song, Hongdan Zhang.   

Abstract

BACKGROUND: Increasing evidence suggests that microRNAs are widely involved in cancer progression and metastasis. However, the specific role of miR-31 in papillary thyroid carcinoma (PTC) is still largely unknown.
METHODS: The level of miR-31 and HuR was detected in 30 pairedcancerous and noncancerous tissue samples using real time PCR. The impact of miR-31 on PTC cell viability and apoptosis was explored using MTT assay and flow cytometry, respectively. To explore the effect of miR-31 on HuR expression, luciferase reporter assay was used.
RESULTS: In papillary thyroid carcinoma patients, miR-31 was significantly down regulated. Furthermore, down regulation of miR-31 increased the proliferation, migration, and invasion of ovarian carcinoma cells. Vice versa, over expression of miR-31 repressed cell invasion and viability. The luciferase reporter assay revealed that HuR was a target for miR-31. Further analysis defined that knockdown of HuR resulted in enhanced cell viability and decreased cell migration rate.
CONCLUSIONS: Down regulation of miR-31 contributed to the malignant progression of papillary thyroid carcinoma cells by targeting HuR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26731986     DOI: 10.7754/clin.lab.2015.150404

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  6 in total

1.  The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection.

Authors:  Howell F Moffett; Adam N R Cartwright; Hye-Jung Kim; Jernej Godec; Jason Pyrdol; Tarmo Äijö; Gustavo J Martinez; Anjana Rao; Jun Lu; Todd R Golub; Harvey Cantor; Arlene H Sharpe; Carl D Novina; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2017-05-22       Impact factor: 25.606

2.  miR 31-3p Has the Highest Expression in Cesarean Scar Endometriosis.

Authors:  Maria Szubert; Anna Nowak-Glück; Daria Domańska-Senderowska; Bożena Szymańska; Piotr Sowa; Aleksander Rycerz; Jacek R Wilczyński
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

3.  Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.

Authors:  Minjia Lu; Xingyu Xu; Baohang Xi; Qi Dai; Chenli Li; Li Su; Xiaonan Zhou; Min Tang; Yuhua Yao; Jialiang Yang
Journal:  Genes (Basel)       Date:  2018-01-19       Impact factor: 4.096

Review 4.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 5.  MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes.

Authors:  Cyril Sobolewski; Laurent Dubuquoy; Noémie Legrand
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

6.  MicroRNA-378 regulates cell proliferation and migration by repressing RNF31 in pituitary adenoma.

Authors:  Peng Qiu; Tong-Jiang Xu; Xiang-Dong Lu; Wei Yang; Yu-Bao Zhang; Guang-Ming Xu
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.